Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. II. Findings in the Era of Highly Active Antiretroviral Therapy (1997 to 2000)

American Journal of Ophthalmology

Volumn 145, Issue 1, 2008, Pages

  Holland, Gary N ^a   Vaudaux, Jean D ^a   Shiramizu, Kevin M ^a   Yu, Fei ^a   Goldenberg, David T ^a   Gupta, Anurag ^a   Carlson, Margrit ^b   Read, Russell W ^c   Novack, Roger D ^a,d   Kuppermann, Baruch D ^e  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DEMOGRAPHY; DRUG TREATMENT FAILURE; DRUG USE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETINITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS TITRATION; VISUAL ACUITY;

EID: 37249003355     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.09.040     Document Type: Article

References (40)

1. Holland G.N., Vaudaux J.D., Jeng S.M., et al. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol 145 (2008) 5-11
2. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853-860
3. Jabs D.A., and Bartlett J.G. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 124 (1997) 227-233
4. Holtzer C.D., Jacobson M.A., Hadley W.K., et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS 12 (1998) 1931-1933
5. Doan S., Cochereau I., Guvenisik N., et al. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol 128 (1999) 250-251
6. Jabs D.A., van Natta M.L., Kempen J.H., et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 133 (2002) 48-61
7. Jacobson M.A., Zegans M., Pavan P.R., et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349 (1997) 1443-1445
8. Holland G.N. New strategies for the management of AIDS-related CMV retinitis in the era of potent antiretroviral therapy. Ocul Immunol Inflamm 7 (1999) 179-188
9. Nussenblatt R.B., and Lane H.C. Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol 125 (1998) 374-382
10. Nettles R.E., Kieffer T.L., Kwon P., et al. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA 293 (2005) 817-829
11. Reed J.B., Schwab I.R., Gordon J., and Morse L.S. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 124 (1997) 199-205
12. Whitcup S.M., Cunningham Jr. E.T., Polis M.A., and Fortin E. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy. Br J Ophthalmol 82 (1998) 845-846
13. Kuppermann B.D., and Holland G.N. Immune recovery uveitis. Am J Ophthalmol 130 (2000) 103-106
14. Kempen J.H., Min Y.I., Freeman W.R., et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 113 (2006) 684-694
15. Holland G.N., Pepose J.S., Pettit T.H., et al. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology 90 (1983) 859-873
16. Jabs D.A. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 93 (1995) 623-683
17. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmol 124 (1997) 141-157
18. Hodge W.G., Boivin J.F., Shapiro S.H., et al. Clinical risk factors for cytomegalovirus retinitis in patients with AIDS. Ophthalmology 111 (2004) 1326-1333
19. Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS-33 states, 2001-2004. MMWR Morb Mortal Wkly Rep 55 (2006) 121-125
20. Winker M.A. Measuring race and ethnicity: why and how?. JAMA 292 (2004) 1612-1614
21. Voelker R. Women shoulder growing HIV/AIDS burden. JAMA 293 (2005) 281-282
22. Trubo R. CDC initiative targets HIV research gaps in Black and Hispanic communities. JAMA 292 (2004) 2563-2564
23. Butcher R.O., Hood R.G., and Jordan W.C. Optimizing treatment for African-Americans and Latinos with HIV/AIDS. J Natl Med Assoc 97 (2005) 1093-1100
24. Wutoh A.K., Hidalgo J., Bareta J., et al. Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome. J Natl Med Assoc 90 (1998) 214-220
25. Kempen J.H., Jabs D.A., Wilson L.A., et al. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 121 (2003) 466-476
26. Kuppermann B.D., Petty J.G., Richman D.D., et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 115 (1993) 575-582
27. Pertel P., Hirschtick R., Phair J., et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 5 (1992) 1069-1074
28. Jacobson M.A., Schrier R., McCune J.M., et al. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis 183 (2001) 1399-1404
29. Piketty C., Weiss L., Thomas F., et al. Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J Infect Dis 183 (2001) 1328-1335
30. Grabar S., Le M., Goujard C., et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. V. Ann Intern Med 133 (2000) 401-410
31. Lin D.Y., Warren J.F., Lazzeroni L.C., et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors. Retina 22 (2002) 268-277
32. Davis M.G., Kenney S.C., Kamine J., et al. Immediate-early gene region of human cytomegalovirus trans- activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A 84 (1987) 8642-8646
33. Skolnik P.R., Kosloff B.R., and Hirsch M.S. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis 157 (1988) 508-514
34. Hammer S.M., Saag M.S., Schechter M., et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 296 (2006) 827-843
35. Holland G.N., Buhles W.C., Mastre B., and Kaplan H.J. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy Study Group. Arch Ophthalmol 107 (1989) 1759-1766
36. Gandhi T., Wei W., Amin K., and Kazanjian P. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy. Clin Infect Dis 42 (2006) 878-884
37. Lucas G.M. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother 55 (2005) 413-416
38. Jabs D.A., van Natta M.L., Thorne J.E., et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology 111 (2004) 2224-2231
39. Lagakos S.W. The challenge of subgroup analyses-reporting without distorting. N Engl J Med 354 (2006) 1667-1669
40. Whitley R.J., Jacobson M.A., Friedberg D.N., et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 158 (1998) 957-969